digital health companies weight loss glp-1 research2guidance Market Overview: GLP-1 Agonists and

Nadolsky became a physician: (2:004:13) What is cardiometabolic medicine?: (4:135:17) What is a healthy metabolism?: (5:177:37) How does diet impact glucose regulation: (7:3710:20) Why has insulin resistance increased in the past decade?: (10:2011:45) Ethnicity impacts BMI cutoffs: (11:4512:57) Is obesity a choice?: (12:5717:40) How socioeconomic status impacts obesity: (17:4021:30) What's better: A BMI score or a DEXA scan?: (21:3025:33) How strength training improves healthspan: (25:3332:32) What a fasting insulin blood test tells you: (32:3236:58) Health risks of insulin resistance: (35:1538:08) How insulin resistance can increase ApoB: (38:0839:25) How does ApoB predict heart disease risk?: (39:2542:50) Why isn't ApoB included in typical lipid panels?: (42:5044:25) Behavioral science and clinical practice: (44:2550:06) How do GLP-1 agonists cause weight loss

Bydureon kept exenatide relevant as newer GLP-1 drugs emerged, but eventually exenatides role diminished since newer agents offered even greater efficacy

Impact of proinflammatory epicardial adipose tissue and differentially enhanced autonomic remodeling on human atrial fibrillation

In controlled experimental models, the peptide is used to analyze feedback loops, signaling cascades, and intracellular response mechanisms

IRE1: ER stress sensor and cell fate executor